5Ania BJ, Suman V J, Sobell JL, et al. Trends in the incidence of polycythemia vera among Olmsted County, Minnesota residents, 1935-1989[J].Am J Hematol, 1994, 47 ( 2 ):89-93.
6Berglund S, Zettervall O.Incidence of polycythemia vera in a definedpopulation[J].EurJ Haematol, 1992, 48 ( 1 ):20-26.
7Jamieson CH, Gotlib J, Durocher JA, et al. The JAK2V617F mutation occurs in hematopoietic stem cells in polycythemia vera and predisposes toward erythroid differentiation[ J ].Proc Nati Acad Sci USA, 2006, 103 ( 16 ): 6224-6229.
8Li Z, Xu M, Xing S, et al. Erlotinib effectively inhibits JAK2V617F activity and polycythemia vera cell growth[J].J Biol Chem, 2007, 282 ( 6 ):3428-3432.
9Gaikwad A, Prchal JT. Study of two tyrosine kinase inhibitors on growth and signal transduction in polycythemia vera[J].Exp Hematol, 2007, 35 (11):1647-1656.
